Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,017 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development and evaluation of low-volume tests to detect and characterize antibodies to SARS-CoV-2.
Halliday A, Long AE, Baum HE, Thomas AC, Shelley KL, Oliver E, Gupta K, Francis O, Williamson MK, Di Bartolo N, Randell MJ, Ben-Khoud Y, Kelland I, Mortimer G, Ball O, Plumptre C, Chandler K, Obst U, Secchi M, Piemonti L, Lampasona V, Smith J, Gregorova M, Knezevic L, Metz J, Barr R, Morales-Aza B, Oliver J, Collingwood L, Hitchings B, Ring S, Wooldridge L, Rivino L, Timpson N, McKernon J, Muir P, Hamilton F, Arnold D, Woolfson DN, Goenka A, Davidson AD, Toye AM, Berger I, Bailey M, Gillespie KM, Williams AJK, Finn A. Halliday A, et al. Among authors: finn a. Front Immunol. 2022 Nov 9;13:968317. doi: 10.3389/fimmu.2022.968317. eCollection 2022. Front Immunol. 2022. PMID: 36439154 Free PMC article.
Evaluation and deployment of isotype-specific salivary antibody assays for detecting previous SARS-CoV-2 infection in children and adults.
Thomas AC, Oliver E, Baum HE, Gupta K, Shelley KL, Long AE, Jones HE, Smith J, Hitchings B, di Bartolo N, Vasileiou K, Rabi F, Alamir H, Eghleilib M, Francis O, Oliver J, Morales-Aza B, Obst U, Shattock D, Barr R, Collingwood L, Duale K, Grace N, Livera GG, Bishop L, Downing H, Rodrigues F, Timpson N, Relton CL, Toye A, Woolfson DN, Berger I, Goenka A, Davidson AD, Gillespie KM, Williams AJK, Bailey M, Brooks-Pollock E, Finn A, Halliday A; CoMMinS Study Team. Thomas AC, et al. Among authors: finn a. Commun Med (Lond). 2023 Mar 15;3(1):37. doi: 10.1038/s43856-023-00264-2. Commun Med (Lond). 2023. PMID: 36922542 Free PMC article.
Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 months.
Santopaolo M, Gregorova M, Hamilton F, Arnold D, Long A, Lacey A, Oliver E, Halliday A, Baum H, Hamilton K, Milligan R, Pearce O, Knezevic L, Morales Aza B, Milne A, Milodowski E, Jones E, Lazarus R, Goenka A, Finn A, Maskell N, Davidson AD, Gillespie K, Wooldridge L, Rivino L. Santopaolo M, et al. Among authors: finn a. Elife. 2023 Jun 13;12:e85009. doi: 10.7554/eLife.85009. Elife. 2023. PMID: 37310006 Free PMC article.
In vitro generated antibodies guide thermostable ADDomer nanoparticle design for nasal vaccination and passive immunization against SARS-CoV-2.
Buzas D, Bunzel AH, Staufer O, Milodowski EJ, Edmunds GL, Bufton JC, Vidana Mateo BV, Yadav SKN, Gupta K, Fletcher C, Williamson MK, Harrison A, Borucu U, Capin J, Francis O, Balchin G, Hall S, Vega MV, Durbesson F, Lingappa S, Vincentelli R, Roe J, Wooldridge L, Burt R, Anderson RJL, Mulholland AJ, Bristol Uncover Group, Hare J, Bailey M, Davidson AD, Finn A, Morgan D, Mann J, Spatz J, Garzoni F, Schaffitzel C, Berger I. Buzas D, et al. Among authors: finn a. Antib Ther. 2023 Oct 17;6(4):277-297. doi: 10.1093/abt/tbad024. eCollection 2023 Oct. Antib Ther. 2023. PMID: 38075238 Free PMC article.
Detection of SARS-CoV-2-specific mucosal antibodies in saliva following concomitant COVID-19 and influenza vaccination in the ComFluCOV trial.
Baum HE, Thirard R, Halliday A, Baos S, Thomas AC, Harris RA, Oliver E, Culliford L, Hitchings B, Todd R, Gupta K, Goenka A, Finn A, Rogers CA, Lazarus R; ComFluCOV Trial Group. Baum HE, et al. Among authors: finn a. Vaccine. 2024 Apr 30;42(12):2945-2950. doi: 10.1016/j.vaccine.2024.03.061. Epub 2024 Apr 4. Vaccine. 2024. PMID: 38580516 Clinical Trial.
Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adults.
Hyams C, Qian G, Nava G, Challen R, Begier E, Southern J, Lahuerta M, Nguyen JL, King J, Morley A, Clout M, Maskell N, Jodar L, Oliver J, Ellsbury G, McLaughlin JM, Gessner BD, Finn A, Danon L, Dodd JW; Avon CAP Research Group. Hyams C, et al. Among authors: finn a. J R Soc Med. 2023 Nov;116(11):371-385. doi: 10.1177/01410768231184162. Epub 2023 Jul 5. J R Soc Med. 2023. PMID: 37404021 Free PMC article.
Relative vaccine effectiveness of mRNA COVID-19 boosters in people aged at least 75 years during the spring-summer (monovalent vaccine) and autumn-winter (bivalent vaccine) booster campaigns: a prospective test negative case-control study, United Kingdom, 2022.
Chatzilena A, Hyams C, Challen R, Marlow R, King J, Adegbite D, Kinney J, Clout M, Maskell N, Oliver J, Finn A, Danon L; Avon CAP Research Group. Chatzilena A, et al. Among authors: finn a. Euro Surveill. 2023 Nov;28(48):2300173. doi: 10.2807/1560-7917.ES.2023.28.48.2300173. Euro Surveill. 2023. PMID: 38037728 Free PMC article.
Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variant between June 2021 and July 2022: A prospective test negative case-control study.
Chatzilena A, Hyams C, Challen R, Marlow R, King J, Adegbite D, Kinney J, Clout M, Maskell N, Oliver J, Danon L, Finn A; Avon CAP Research Group. Chatzilena A, et al. Among authors: finn a. Lancet Reg Health Eur. 2022 Dec 7;25:100552. doi: 10.1016/j.lanepe.2022.100552. eCollection 2023 Feb. Lancet Reg Health Eur. 2022. PMID: 36506791 Free PMC article.
1,017 results